| Předmět: |
|
| Zdroj: |
Drug Week; 4/7/2023, p2363-2363, 1p |
| Abstrakt: |
Keywords: Kazan; Russia; Amitriptyline Therapy; Antidepressants; Biosensors; Biotechnology; Chemicals; Dibenzocycloheptenes; Drugs and Therapies; Electrochemicals; Emerging Technologies; Enzymes and Coenzymes; Health and Medicine; Monoamine Oxidase; Nanoparticles; Nanotechnology; Oxidase; Oxidoreductases Acting on CH-NH2 Group Donors; Pharmaceuticals; Psychotherapeutic Agents; Tricyclic Antidepressants EN Kazan Russia Amitriptyline Therapy Antidepressants Biosensors Biotechnology Chemicals Dibenzocycloheptenes Drugs and Therapies Electrochemicals Emerging Technologies Enzymes and Coenzymes Health and Medicine Monoamine Oxidase Nanoparticles Nanotechnology Oxidase Oxidoreductases Acting on CH-NH2 Group Donors Pharmaceuticals Psychotherapeutic Agents Tricyclic Antidepressants 2363 2363 1 04/03/23 20230407 NES 230407 2023 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Biosensors. Here, we consider the features of amperometric monoamine oxidase biosensors based on screen-printed graphite electrodes modified with nanocomposite consisting of C-60/cobalt nanoparticles/amino derivative of a second-generation polyether polyol/chitosan in the determination of the tricyclic antidepressant amitriptyline.". [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
